We are live on ! Find out more
AERI

Aerie Pharmaceuticals

Delisted

AERI was delisted on the 18th of November, 2022.

0 hedge funds and large institutions have $0 invested in Aerie Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 153 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1560 (-156)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

100% less capital invested

Capital invested by funds: $703M → $0 (-$703M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 153

Holders
Holders Change
-156
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
153
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
126
Tower Research Capital (TRC)
New York
-$66K -4,342 Closed
Simplex Trading
127
Simplex Trading
Illinois
-$62K -4,120 Closed
US Bancorp
128
US Bancorp
Minnesota
-$59K -3,944 Closed
AIP
129
Ameritas Investment Partners
Nebraska
-$56K -3,728 Closed
MA
130
Montag & Associates
Georgia
-$52K -3,408 Closed
Osaic Holdings
131
Osaic Holdings
Arizona
-$49K -3,307 Closed
MLICM
132
Metropolitan Life Insurance Company (MetLife)
New York
-$45.2K -2,986 Closed
LIM
133
Longfellow Investment Management
Massachusetts
-$36K -2,385 Closed
CG
134
Cutler Group
California
-$30K -2,000 Closed
Canada Life
135
Canada Life
Manitoba, Canada
-$27K -1,817 Closed
Group One Trading
136
Group One Trading
Illinois
-$24K -1,576 Closed
QT
137
Quantbot Technologies
New York
-$18K -1,222 Closed
Fidelity Investments
138
Fidelity Investments
Massachusetts
-$17K -1,114 Closed
Federated Hermes
139
Federated Hermes
Pennsylvania
-$12K -802 Closed
Nisa Investment Advisors
140
Nisa Investment Advisors
Missouri
-$11K -739 Closed
QCG
141
Quadrant Capital Group
Ohio
-$9K -600 Closed
LJHT
142
Laurie J. Hall Trustee
-$7K -485 Closed
CUAMC
143
China Universal Asset Management Company
China
-$7K -463 Closed
GIA
144
GHP Investment Advisors
Colorado
-$6K -400 Closed
S
145
SignatureFD
Georgia
-$6K -395 Closed
TWM
146
Tradition Wealth Management
Minnesota
-$3K -167 Closed
KFI
147
Key Financial Inc
Pennsylvania
-$2K -150 Closed
PNC Financial Services Group
148
PNC Financial Services Group
Pennsylvania
-$2K -116 Closed
Daiwa Securities Group
149
Daiwa Securities Group
Japan
-$2K -102 Closed

AERI Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2022, worth a combined $0 — down 100% from $703M a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of AERI and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $73.5M sold.

  • 0 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2022, down from 156 in Q3 2022.
  • Funds reported $0 of Aerie Pharmaceuticals stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Aerie Pharmaceuticals positions in Q4 2022 and 153 closed out, a net change of -153 holders.
  • The largest Aerie Pharmaceuticals seller in Q4 2022 was Deerfield Management, an estimated $73.5M sold.

Based on aggregated 13F filings for Q4 2022.